Back to dashboard
MedicaidCoverageHigh impact

Newsletter Vol. 12, No. 19

New Jersey Medicaid·NJ · Pharmacy·Pharmacy
Effective date
Apr 1, 2002
We identified it
Jun 20, 2026
Days to comply

Summary

New Jersey Medicaid and NJ FamilyCare are adding 6 new pharmaceutical manufacturers to their drug rebate program (effective immediately in January-February 2002) and deleting 13 manufacturers effective April 1, 2002. Drugs from deleted manufacturers will no longer be reimbursed by these programs. Billing teams must update their pharmacy system records to reflect these manufacturer labeler code changes to avoid claim denials.

Action Required

Action needed
REQUIREMENTS: 1. IMMEDIATE (upon receipt): Billing team must obtain and review the complete manufacturer labeler code lists for both additions (effective 01/24/2002 - 02/05/2002) and deletions (effective 04/01/2002). Contact Pharmaceutical Services at (609) 588-2724 or Unisys Provider Services at (800) 776-6334 to obtain full APPENDIX F documentation. 2. By March 31, 2002: Update pharmacy billing system and claims submission software to remove the following manufacturer labeler codes from reimbursable drug lists: 00263, 00524, 00662, 00663, 59012, 00761, 10337, 11414, 52891, 11793, 54162, 58174, 58948, 70030, 71114 (manufacturers: Integra Lifesciences, Knoll Pharmaceutical, Pfizer Pharmaceuticals Group, Basic Drugs Inc., Bradley Pharmaceuticals, Baker Norton Pharmaceuticals, Aventis Pasteur, Geritrex Corporation, Baker Cummins Dermatologicals, L. Perrigo Company, and Circa Pharmaceuticals). 3. Immediately: Add new manufacturer labeler codes 55298 (3M Pharmaceuticals), 64406 (IDEC Pharmaceuticals), 65893 (Cody Laboratories), 66203 (Organon Sanofi-Synthelabo), 66530 (Spear Dermatology Products), and 66813 (Athlon Pharmaceuticals) to reimbursable manufacturer lists in billing system. 4. Before April 1, 2002: Notify prescribing providers of deleted manufacturers so they can adjust prescribing patterns. Update formulary lists and internal documentation. 5. On/After April 1, 2002: All claims for drugs from deleted manufacturers will be denied by NJ Medicaid and NJ FamilyCare fee-for-service programs. No reimbursement will be processed. 6. Retain this newsletter in provider records and file numerically behind the Newsletter tab (Blue Tab marked "5").